Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Molecular Biology Team hosts the Botnar Sequencing Small Research Facility, which provides Next Generation Sequencing via an Illumina NextSeq 500. Complementing this, the group has expertise in library preparation for RNAseq, ChIPseq and ATACseq, as well as bespoke assay development, for batch sizes up to 96 samples.

In close cooperation with the Computational Biology Team, these techniques have been used to explore many of the group’s research interests, including iPSC and mesenchymal stem cell differentiation, somatic cell reprogramming, pathomechanisms of uterine fibroids, drug response of bone and mesenchymal cancers and the epigenetics of inflammatory diseases.


Single cell sequencing has become a focus of the group, with cell sorting capabilities provided by a Sony SH800 FACS and single cell encapsulation for Drop-seq using the Nadia Innovate System.  Using this powerful technique the group has been able to identify distinct cellular subtypes within populations previously thought of as homogeneous and monitor changes to lymphocyte populations following drug exposure.


The group makes extensive use of various knockdown technologies including siRNAs, LNAs, lentiviral shRNAs and lentiviral CRISPRi/a and maintains a comprehensive collection of small molecule inhibitors targeting proteins involved in epigenetic processes.  Custom pooled lentiviral shRNA or CRISPR libraries targeting >400 epigenetic targets in combination with NGS allows the rapid identification of key epigenetic processes.


Plasmid cloning supports many of the projects within the group as well as the activities of the Structural Biology Team.  The group also heavily utilises immunohistochemistry, particularly for the validation of putative targets identified by systems biology approaches.


The Oppermann Molecular Biology Group collaborates widely within the Department, across the University of Oxford, nationally and internationally to provide access to the groups capabilities.

Key Technologies

Next Generation Sequencing 




Single cell sequencing 


Lentiviral CRISPR and  shRNAs